FDA issues warning letters to pet CBD companiesMay 3, 2025The U.S. Food and Drug Administration (FDA) has warned three pet CBD companies about illegally marketing unapproved products with unsubstantiated health claims.
SPONSORED CONTENTThe Case for Year-Round Heartworm Prevention and Affordable OptionsVeterinarians are often more than just clinicians - they’re advisors, educators, and, increasingly, financial counselors. In today’s economy, pet owners may hesitate to invest in year-round prevention due to budget constraints; but, skipping even a few months of heartworm protection can have serious consequences. + Learn More
California tops list of marijuana toxicity cases in pets, new data showsApril 21, 2025Check out the insights from Trupanion’s latest data, showing rising marijuana toxicity in pets in the last five years.
FDA seeks public input on cannabis-derived products in vet medFebruary 3, 2025The U.S. Food and Drug Administration (FDA)’s Center for Veterinary Medicine aims to get information on overall trends related to these products, including adverse effects, safety issues, and toxicological risks.
Efficacy of cannabinoids in veterinary medicineMay 8, 2024Although the use of cannabinoids, particularly CBD-rich hemp products, is in its infancy in veterinary medicine, there appears to be optimism regarding its utilization concurrently with other therapeutics for a range of disorders, including epileptic seizure control, pain associated with osteoarthritis, and atopic dermatitis.
VPN Plus+ ExclusiveCurrent Literature Review of Cannabinoids for Pain in Veterinary SpeciesMarch 8, 2024In this session: Stephen Niño Cital, RVT, SRA, RLAT, CVPP, VTS (LAM-Res. Anesthesia), discusses our current understanding of cannabinoids and their use for pain management in veterinary species. He also addresses the most current studies from design to results and how this applies to practice.
Cannabinoids: It's all about the petNovember 6, 2023The use of cannabinoids in veterinary medicine is growing. What is less clear is the treatment across veterinary species, and the first necessary step into the use of cannabidiol (CBD) and cannabidiolic acid (CBDA) is to assess the pharmacokinetics in the species of intent.
Is CBD a better option than NSAIDs?October 2, 2023CBD has amassed evidential support and transparent quality control. Could it provide a suitable treatment choice? Certainly, more remains to be known about dosing and drug-herb interactions.
Pet cannabinoids brand expands into EuropeFebruary 21, 2023Portland, Maine-based pet CBD+CBDA company, ElleVet Sciences, opens new headquarters in Haarlem, the Netherlands.
VPN Plus+ ExclusiveCannabinoids in the Clinic: Practical ApproachesJanuary 19, 2023In this session: The clinical data for companion animals with the use of cannabinoids, like CBD, has been growing. Stephen Niño Cital, RVT, SRA, RLAT, CVPP, VTS-LAM (Res. Anesthesia) discusses the current and relevant literature and dosing for safe and effective use of CBD in your practice.
Multi-modal approach can help ease patient stressNovember 10, 2022Fear Free, LLC, has joined forces with veterinary cannabidiol (CBD) company, ElleVet Sciences. The partnership aims to give pets the “highest level of success in handling stressful situations” by helping them respond to the positive reinforcement methods practiced by Fear Free-certified veterinarians, ElleVet Sciences reports.
